Chemotherapeutic Strategies for Resectable Colorectal Liver Metastases

Colon cancer remained the third leading cause of death in the United States for both men and women in 2008. Of the patients who develop metastatic disease, approximately 60% will present with metachronous disease and 40% will present with synchronous disease.